Independent Analyses To Inform Go/No-go Decisions
Publié le
Our client in this case was an investment organization specialized in biotechnology companies, and they required an urgent analysis of…
Clinical Validity Of Circulating Tumor Cells (CTC)
Publié le
Assessment of Clinical Validity of Circulating Tumor Cells (CTC) Quantification Clinical Validity Of Circulating Tumor Cells (CTC) In Patients With…
Developing New Biomarkers And Diagnostic Tests
Publié le
Biostatistical Expertise For Developing New Biomarkers And Diagnostic Tests IDDI has a long-term collaboration with a Sponsor to provide biostatistical…
Meta-Analysis To Assess Efficacy in Colorectal Cancer
Publié le
In this meta-analysis, tumor responses and survival were analyzed combining the data from the different trials using patient individual data. The…
Jumping Ahead to Phase III trial
Publié le
A new ophthalmic drug was going to enter a phase II dose-ranging trial in order to determine the dose to…
Meta-Analysis of Clinical Trials to Support New Drug Approval
Publié le
Meta-Analysis performed with IDDI’s Methodology Skills IDDI has been involved in numerous meta-analyses to directly or indirectly support new drug applications….
Anti-cancer drug approved based on a surrogate endpoint
Publié le
Surrogate endpoint for overall survival We managed to prove, using data from a randomized trial comparing Ceplene + IL-2 to…